Question 1

What are the specific benefits of participating in this trial compared to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma clinical trial (NCT06919939). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the combination of Epcoritamab and Loncastuximab Tesirine be administered?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma clinical trial (NCT06919939). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from these treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma clinical trial (NCT06919939). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma clinical trial (NCT06919939). Contact the study team or your healthcare provider for specific answers.

Question 5

What tests or procedures will be required during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma clinical trial (NCT06919939). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any risks associated with participating in this trial that I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma clinical trial (NCT06919939). Contact the study team or your healthcare provider for specific answers.

What this study is about